Research

Limit: 1 // Tickets Available: 0

A. Wilson (Public Health)

Limiting Language
Only one applicant from a university or non-profit research institute will be considered in each application cycle. Institutions should have an internal screening and selection process, as the Foundation will not consider multiple letters of intent received from a single institution. For purposes of this limitation, the Foundation considers the overseeing university to be the institution. Thus, a university with a law school, medical school, several teaching hospitals, and a faculty of arts and sciences may only submit one application in total. If a university system, such as a state-wide university system, comprises several universities, each university within the system may nominate one applicant.

Program Overview
The Greenwall Faculty Scholars Program in Bioethics is a career development award to enable early-career faculty members to carry out innovative bioethics research. It supports research that goes beyond current work in bioethics to help resolve pressing ethical issues in clinical, biomedical, and public health decision-making, policy, and practice, and creates a community that enhances future bioethics research by Scholars and Alums.

Each year, the Foundation selects approximately three Greenwall Faculty Scholars to receive 50 percent salary support for three years to enable them to carry out a specific research proposal and develop their research program.

Scholars and Alums attend twice-yearly meetings, where they present their works in progress, receive feedback and mentoring from the Faculty Scholars Program Committee and other Scholars and Alums, and have the opportunity to develop collaborations with other researchers. Third-year Scholars are expected to help plan these meetings. Ongoing involvement of Alums with the Program provides continued opportunities for professional development and feedback, and engages them in mentoring of early-career Scholars. In addition, all first-year Scholars participate in a philosophical bioethics seminar series; additional professional development opportunities may also be offered.

The Program Committee provides oversight and direction for the Program and is involved not only with selection of the Scholars but also with mentoring and professional development activities. 
 

Apply to Internal Competition // Limit: 4 // Tickets Available: 4

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language
Applications are limited to four per institution per receipt date including new (A0), resubmissions (A1) and renewal (T2); NCI-designated cancer center consortia are considered one institution. NCI seeks a broad representation of institutions for this award mechanism and may take this into account when making funding decisions.

Purpose
Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for the Research Specialist Award in any area of NCI-funded clinical cancer research. This NOFO is specifically for clinician scientists to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees, and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. The Research Specialist Award is intended to provide stable support for clinician scientists at their institutions for significant leadership and exceptional participation in the NCI-sponsored clinical trials networks that conduct cancer treatment, prevention and control, and care delivery clinical trials. NCI-sponsored clinical trials networks include but are not limited to the National Clinical Trials Network (NCTN), the NCI Community Oncology Research Program (NCORP), the Experimental Therapeutics Clinical Trials Network (ETCTN), and the Cancer Prevention Clinical Trials Network (CP-CTNet).

The Research Specialist Award is designed to encourage the development of a career path for cancer clinical trial investigators who provide leadership, participation, and scientific support for the NCI clinical trials networks at their institutions and within those networks. This leadership includes the development of concepts and protocols for clinical trials, participation in scientific steering committees and network committees, and accrual to NCI-sponsored clinical trials. The institutional activities may include the implementation of cancer clinical trials including participation in the review of safety data, monitoring the conduct and progress of open clinical trials, and serving on institutional review committees. These activities are necessary for the successful conduct of NCI-sponsored cancer clinical trials. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of funding for cancer research career continuity.

Request Ticket // Limit: 1 per department 

L. O'Neill - (Center on Aging)

Limiting Language
My organization is a government, a tribal entity, or a university: You may submit one application per department. You may submit another if, and only if, you are collaborating with another organization.  
o If you would like to submit a second application on behalf of a collaborative group of organizations, submit only one application per project. This means choosing just one organization to submit the collaborative application.  
o If several departments are applying for the same project, please treat it as a collaborative application. 
o A government or tribal agency, or university may apply for projects separate from those the individual departments apply for.   

Grant Description
All organizations requesting grants must provide services that directly benefit populations residing in Cochise County and eastern Santa Cruz Counties. 

The Legacy Foundation of Southeast Arizona is seeking applications for Innovative grants.  

Grant Cycle – June 2, 2025 through September 26, 2025. Awards will be announced by December 13, 2025.  Grants will be awarded January 2026.  

Every year the Legacy Foundation of Southeast Arizona funds Innovation Grants for projects up to $50,000 that are aligned with the Foundation Mission of Promoting Population Health and Community Wellness. 

Collaboration and forging partnerships with other community organizations are key determinants in funding decisions. 

The Legacy Foundation of Southeast Arizona will kick off the Innovative Grant Cycle with a workshop that will provide full information regarding the goals of the cycle. 
 

Apply to Internal Competition // Limit: 3 // Tickets Available: 3

Limiting Language:

Each PPP is limited to a maximum of four PIs. No university shall exceed leading three PPPs. Candidate must be a University Consortium Member prior to submitting a Notice of Intent (NOI)

Topics: 

1. TOPIC 1: IMPROVED SUB-SCALE HYPERSONIC AIR-BREATHING PROPULSION TEST CAPABILITIES  
2. TOPIC 2: DIGITAL TWIN ARCHITECTURE FOR HYPERSONIC AIR-BREATHING SYSTEM AND MISSION DESIGN TRADE STUDIES
3. TOPIC 3: SHOCK PROPERTIES OF ADDITIVELY MANUFACTURED MATERIALS (AMM)
4. TOPIC 4: EXPERIMENTAL & MODEL BASED ENDOTHERMIC FUEL PROPERTIES
5. TOPIC 5: CERAMIC TESTING FOR HYPERSONIC VEHICLES
6. TOPIC 6: MITIGATION OF THERMAL DEGRADATION IN HYPERSONIC WINDOWS
7. TOPIC 7: NETWORKING AND COLLABORATIVE COMMUNICATIONS 

Questions regarding the Project Call may be emailed to UCAH@tamu.edu through September 5, 2025 at 5:00 PM EST. Answers to the questions will be posted on the UCAH website for this RPP Project Call. All questions and answers will be made available to all proposers, unless they involve proprietary or CUI material. 

Request Ticket // Limit: 2 per department

Limiting Language
Applicants must be approved by their department to apply for the PBF Fellowship. Institutions may have no more than three Parker B. Francis Fellows in a single department at a given time, a department may submit nor more than two applications annually, and a mentor may sponsor only one application annually.

Executive Summary
The Parker B. Francis Fellowship provides research support to clinical and basic scientists embarking on careers in clinical, laboratory or translational science related to Pulmonary, Critical Care and Sleep Medicine at a U.S. or Canadian university or research institution. The ideal candidate is one with evidence of strong aptitude in research and who is in transition from post-doctoral trainee to independent investigator. It is essential that there be evidence of accomplishment and proficiency in research. Few applicants who are just beginning research training and have only one or two research publications are funded.

Limit: 1 // Tickets Available: 0

K. Huntoon (Neurosurgery)

Goal and Focus  

The goal of these grants is to overcome barriers to the clinical application of new treatment approaches for childhood cancer. A priority is to fund projects that have already shown great promise, but that have a specific funding need to move forward. 

The three main focus areas for this RFP are:  

• Cancer immunotherapy or targeted therapy  

• High-grade brain tumors or other difficult-to-treat pediatric cancers  

• Epigenetic modifying therapy or gene therapy  Applications of novel technologies (e.g. nanotechnology, omics, gene editing, bioinformatics, and AI) in these areas are welcome. 

Eligibility  

• Applications will only be accepted from Children’s Oncology Group member institutions in North  America (no citizenship requirements).  

• Open to PIs at all academic ranks with MD and/or PhD  

• Limit of one application per institution for either the Collaborative or the Individual grant with the  endorsement of the Chief(s) of the Division(s) of Pediatric Hematology-Oncology.  

 

Apply to internal competition // Limit: 2* // Tickets Available: 2

*The first submission may address any cancer type. A second submission is allowed but only for a translational or clinical stage project that primarily focuses on one of the following four cancer types: upper GI, glioblastoma, triple-negative breast cancer, or pancreatic cancer.

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Purpose of the Award
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. Basic, translational, and clinical projects are eligible. The project must seek to address an overarching, urgent scientific question. We welcome projects addressing substantial unmet needs in any type of cancer. We particularly encourage teams with innovative ideas for therapeutic strategies for upper GI, glioblastoma, triple-negative breast cancer, and pancreatic cancer to consider applying in this round.

Limit: 3 // Tickets Available: 0

M. Bhattacharya (Neuroscience)
J. Streicher (Pharmacology)
K. Huntoon (Neurosurgery)

The mission of The G. Harold and Leila Y. Mathers Foundation is to advance knowledge in the life sciences by sponsoring scientific research that will benefit mankind. The foundation’s grants program seeks to support basic science, ideally with potential translational applications. Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.

For many years the Foundation has enjoyed special recognition in the research community for supporting “basic” scientific research, realizing that true transformative breakthroughs usually occur after a thorough understanding of the fundamental mechanisms underlying natural phenomena. More recently, and with the advent of newer investigative methodologies, technology, and tools, the Foundation now embraces innovative translational research proposals.

The grant duration must be three years. The budget should be reasonable based on the aims of the project. Indirect costs may not exceed 10%. Preliminary Budgets are required during the LOI phase. A detailed budget justification is not required until the proposal phase. The Foundation’s grant award is not intended to be utilized for purchasing capital equipment (“bricks-and-mortar”) for the lab and is intended only to support the actual investigation. The Foundation assumes and expects that capital equipment must be provided by the research institution or university.

Application Guidance:

• Grant budgets cannot exceed $600-750K
• The Foundation primarily supports basic science, ideally with potential translational applications.
• Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.
• Covid-19-related research projects (aims or sub-aims) will not be considered for support.
• Medical imaging technology-related projects and/or electrical engineering technology development projects will not be considered for support.
• Plant Biology Research, Oceanography, Space Exploration. and Global warming-related research will not be considered for support.
• As technology continues to advance, it is apparent that investigations in the area of basic science and translational research may become more and more reliant on collaborative, interdisciplinary projects. It is important to note that any interdisciplinary project proposals may require additional information regarding the collaborator(s)’ achievements and relevant expertise.
• Feedback for declined LOI Requests will not be provided; LOIs or Formal Proposals that have been declined should not be resubmitted at a later date for consideration.
• Renewal applications for the same or related research will not be accorded priority consideration. It is strongly advised that any re-application for grant renewal consider a new direction based on prior research or emphasize some new potential translational aspects and not merely an extension of previously funded research.
• Requests for funding previously federally supported research and/or applications pending federal approval will not be accorded priority consideration.
• Requests for support of clinical trials or drug discovery will not be approved. The Foundation will not support projects which we consider pre-clinical drug development.

Fall 2025

Nominations and Portal Registration due date: September 19, 2025 (Friday, 8 PM EST (5 PM PST)
Nominations can be submitted beginning August 1, 2025.

Due date for LOI applications: October 3, 2025 (Friday, 8 PM EST (5 PM PST) 
Applicants notified of proposal invitation or LOI rejection within one month of the due date. 

Due date for invited formal proposals: December 12, 2025 (Friday, 8 PM EST (5 PM PST) 
Applicants are notified of proposal approval or rejection within 2 ½ months of the due date. 

 *Late nominations and/or registrations will not be approved.
 

Limit: 1 // Tickets Available: 0 

J. Stevens Aubrey (Communications) 

Summary
The Huo Family Foundation invites applications for special projects. These larger and longer-term research awards would allow researchers of all career stages, collaborating as a multi-disciplinary team with different expertise and skills, to take an integrated approach to tackle the more difficult questions in this domain. 

Proposals should be tackling key questions within the broad topic of the effects of usage of and exposure to digital technologies on brain development and function (including physiological responses), social behaviour and interactions, and mental health of children and young people.

Awarded research grants in this area can be held at colleges, universities and research institutes in the UK and in the US.

We are keen to support multi-disciplinary work. These teams may consist of several group leaders from one institution, or different institutions in the UK and the US. 

Eligibility 
PLEASE NOTE WE WILL CONSIDER ONLY ONE SPECIAL PROJECT PROPOSAL FROM EACH LEAD INSTITUTION. THE LEAD INSTITUTION IS THE COLLEGE, UNIVERSITY OR RESEARCH INSTITUTE WHERE THE LEAD APPLICANT IS LOCATED. 

Limit: 1 // Tickets Available: 0

J. Burgess (Public Health)

Executive Summary
The focus of the Fiscal Year (FY) 2024 Fire Prevention and Safety (FP&S) Grant Program (hereafter referred to as the FP&S Program) is to enhance the safety of the public and firefighters with respect to fire and fire-related hazards. The FP&S Program provides grants directly to eligible entities for fire prevention programs and firefighter health and safety research and development.

Eligibility
The maximum number of applications that can be submitted is: 1. One application per eligible entity, per activity (up to one application under the FP&S Activity (not eligible) and up to one application under the R&D Activity)

Each application may include up to three projects. Each project withinan application must be presented separately as a free-standingproposal. Each project requires its own separate supporting budget and narrative statement.

If an applicant submits two or more applications for the same activity, both applications may be disqualified. 

• This is different from when an entity is applying on behalf of other organizations that are agencies or instrumentalities of the applicant (e.g., multiple fire departments under the same county, city, borough, parish, or other municipality)
• In that situation, the applicant may request similar or the same costs as long as the application clearly states which costs (including quantities) are for which agency/instrumentality
• This is permissible even if that entity submits multipleapplications across regional versus direct applications